Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial

Floris H.B.M. Schreuder, Catharina J.M. Klijn, Isabelle C. Van Gelder et al.|The Lancet Neurology|2021

Cited by 101